ESMO 2025: Data, decisions, and the future of oncology
The ESMO Congress 2025 once again demonstrated why it stands at the forefront of global oncology. Across five days in Berlin, the world’s leading clinicians, researchers, and pharmaceutical innovators gathered to reveal late-stage clinical data and discuss the future of cancer treatment. The event reaffirmed ESMO’s status as a defining moment in the oncology calendar - where new science meets strategic insight.
